Under the terms of its distribution agreement with W. L. Gore & Associates, Conmed (CNMD) has held exclusive U.S. and Canadian distribution rights for the Gore Viabil biliary stent. As previously disclosed in its latest 10-Q filing, Conmed did not plan to renew this agreement beyond December 31, 2026. Following a strategic review, the company elected to accelerate this timeline, concluding the agreement effective January 1, 2026. Financial terms of the agreement were not disclosed.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD: